Henryk Barthel, Matthias Brendel, Nathalie Albert, Henning Boecker, Caroline Bouter, Joachim Brumberg, Ralph Buchert, Christian La Fougère, Gerhard Gründer, Swen Hesse, Torsten Kuwert, Catharina Lange, Karl J Langen, Philipp Lohmann, Philipp T Meyer, Isabelle Miederer, Bernd Neumaier, Axel Rominger, Mathias Schreckenberger, Jörg B Schulz, Igor Yakushev, Alexander Drzezga
{"title":"Updated Procedure Guideline of the German Society of Nuclear Medicine for Amyloid Brain PET Imaging 3.0.","authors":"Henryk Barthel, Matthias Brendel, Nathalie Albert, Henning Boecker, Caroline Bouter, Joachim Brumberg, Ralph Buchert, Christian La Fougère, Gerhard Gründer, Swen Hesse, Torsten Kuwert, Catharina Lange, Karl J Langen, Philipp Lohmann, Philipp T Meyer, Isabelle Miederer, Bernd Neumaier, Axel Rominger, Mathias Schreckenberger, Jörg B Schulz, Igor Yakushev, Alexander Drzezga","doi":"10.1055/a-2784-7335","DOIUrl":null,"url":null,"abstract":"<p><strong>Preamble: </strong>This represents a substantial development of the guideline on the topic first published in 2016. The following notable points have been updated: the sections on background information; the clinical benefit of the method; the resulting differential diagnostic considerations; the outlook for possible future extensions of the indication spectrum; the quantitative analysis of the PET images; the embedding of the method in diagnostic pathways; and the relation to alternative biomarker methods such as amyloid measurement in CSF/blood.</p>","PeriodicalId":94161,"journal":{"name":"Nuklearmedizin. Nuclear medicine","volume":"65 3","pages":"223-235"},"PeriodicalIF":1.2000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nuklearmedizin. Nuclear medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/a-2784-7335","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/5/21 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Preamble: This represents a substantial development of the guideline on the topic first published in 2016. The following notable points have been updated: the sections on background information; the clinical benefit of the method; the resulting differential diagnostic considerations; the outlook for possible future extensions of the indication spectrum; the quantitative analysis of the PET images; the embedding of the method in diagnostic pathways; and the relation to alternative biomarker methods such as amyloid measurement in CSF/blood.